• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
October 2008
October 2008

Behavior Management Help Guide
Behavior Management Help Guide

CASE STUDY OF OLIVIA
CASE STUDY OF OLIVIA

Neuropsychiatric Features of Celiac Disease
Neuropsychiatric Features of Celiac Disease

Alterations of Mitochondria and Golgi Apparatus Are
Alterations of Mitochondria and Golgi Apparatus Are

Insulin Resistance, Affective Disorders, and Alzheimer`s
Insulin Resistance, Affective Disorders, and Alzheimer`s

... clinically. The report that depressive episodes preceding the onset of dementia by 10 years appear to double AD risk supports this postulate, as do numerous earlier findings (94). Major disorders of insulin regulation have been associated with both ad (95) and AD (48), including diabetes, obesity, a ...
Detection of grey matter loss in mild Alzheimer`s disease
Detection of grey matter loss in mild Alzheimer`s disease

... entorhinal cortex are believed to have high sensitivity and specificity in the detection of AD from non-demented elderly controls1 2 and can predict conversion of mild cognitive impairment to AD.3 However, the variability of the measurements because of the human tracer has so far limited direct comp ...
Summary Antipsychotic medications are overused in Australia as a
Summary Antipsychotic medications are overused in Australia as a

... certain neurotransmitters in the brain, thereby reducing psychotic symptoms (hallucinations or delusions), and creating a sedative effect. They are also associated with common and serious side-effects; metabolic, movement and mood ...
2007 MIND Research Review - MassGeneral Institute for
2007 MIND Research Review - MassGeneral Institute for

Behavioral Management and Psychosocial Interventions
Behavioral Management and Psychosocial Interventions

Fundamentals of Nuclear Medicine Brain Imaging
Fundamentals of Nuclear Medicine Brain Imaging

Management of patients receiving Cholinesterase Inhibitors
Management of patients receiving Cholinesterase Inhibitors

neurodegenerative atypical parkinsonism
neurodegenerative atypical parkinsonism

from the Lewy body dementia association
from the Lewy body dementia association

Dementia: Cognitive Assessment - American Psychiatric Association
Dementia: Cognitive Assessment - American Psychiatric Association

... None ...
PD Lecture 1999 - University of Pittsburgh
PD Lecture 1999 - University of Pittsburgh

Vascular Diseases - University of Pittsburgh
Vascular Diseases - University of Pittsburgh

Epilepsy in neuronal ceroid lipofuscinoses
Epilepsy in neuronal ceroid lipofuscinoses

Lecture 7 Protein Folding
Lecture 7 Protein Folding

A Survey Study of Neuropsychiatric Complaints in Patients
A Survey Study of Neuropsychiatric Complaints in Patients

Frontotemporal dementia – Differentiation from Alzheimer`s disease
Frontotemporal dementia – Differentiation from Alzheimer`s disease

nightmares without atonia as an early symptom of diffuse lewy
nightmares without atonia as an early symptom of diffuse lewy

Parkinson`s Disease
Parkinson`s Disease

Synthetic cannabinoids in dementia with agitation
Synthetic cannabinoids in dementia with agitation

Transmissible spongiform encephalopathies
Transmissible spongiform encephalopathies

< 1 ... 19 20 21 22 23 24 25 26 27 ... 47 >

Alzheimer's disease



Alzheimer's disease (AD), also known as Alzheimer disease, or just Alzheimer's, accounts for 60% to 70% of cases of dementia. It is a chronic neurodegenerative disease that usually starts slowly and gets worse over time. The most common early symptom is difficulty in remembering recent events (short-term memory loss). As the disease advances, symptoms can include problems with language, disorientation (including easily getting lost), mood swings, loss of motivation, not managing self care, and behavioural issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the average life expectancy following diagnosis is three to nine years.The cause of Alzheimer's disease is poorly understood. About 70% of the risk is believed to be genetic with many genes usually involved. Other risk factors include a history of head injuries, depression, or hypertension. The disease process is associated with plaques and tangles in the brain. A probable diagnosis is based on the history of the illness and cognitive testing with medical imaging and blood tests to rule out other possible causes. Initial symptoms are often mistaken for normal ageing. Examination of brain tissue is needed for a definite diagnosis. Mental and physical exercise, and avoiding obesity may decrease the risk of AD. There are no medications or supplements that decrease risk.No treatments stop or reverse its progression, though some may temporarily improve symptoms. Affected people increasingly rely on others for assistance, often placing a burden on the caregiver; the pressures can include social, psychological, physical, and economic elements. Exercise programs are beneficial with respect to activities of daily living and can potentially improve outcomes. Treatment of behavioral problems or psychosis due to dementia with antipsychotics is common but not usually recommended due to there often being little benefit and an increased risk of early death.In 2010, there were between 21 and 35 million people worldwide with AD. It most often begins in people over 65 years of age, although 4% to 5% of cases are early-onset Alzheimer's which begin before this. It affects about 6% of people 65 years and older. In 2010, dementia resulted in about 486,000 deaths. It was first described by, and later named after, German psychiatrist and pathologist Alois Alzheimer in 1906. In developed countries, AD is one of the most financially costly diseases.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report